Results 21 to 30 of about 132,133 (266)

ANXA11 rs1049550 Associates with Löfgren’s Syndrome and Chronic Sarcoidosis

Cells, 2022
Sarcoidosis is an immune mediated granulomatous disease commonly affecting the lungs. Genome wide association studies identified many genomic regions that are shared among multiple immune mediated diseases.
Bekir Karakaya, Joanne J. van der Vis, Marcel Veltkamp, Douwe H. Biesma, Jan C. Grutters, Coline H. M. van Moorsel   +5 more
doaj   +1 more source

Telomerase Reverse Transcriptase Polymorphism rs2736100: A Balancing Act between Cancer and Non-Cancer Disease, a Meta-Analysis

Frontiers in Medicine, 2018
The enzyme telomerase reverse transcriptase (TERT) is essential for telomere maintenance. In replicating cells, maintenance of telomere length is important for the preservation of vital genetic information and prevention of genomic instability.
Reinier Snetselaar, Matthijs F. M. van Oosterhout, Jan C. Grutters, Jan C. Grutters, Coline H. M. van Moorsel, Coline H. M. van Moorsel   +5 more
doaj   +1 more source

Progression of radiographic fibrosis in rheumatoid arthritis-associated interstitial lung disease

Frontiers in Medicine, 2023
Background and objectivesPreclinical interstitial lung disease (pILD) may represent the early stages of rheumatoid arthritis-associated interstitial lung disease (RA-ILD).
Dandan Chai, Di Sun, Yuanying Wang, Yawen Song, Na Wu, Na Wu, Qiao Ye, Qiao Ye   +7 more
doaj   +1 more source

The Role of Cutibacterium acnes in Sarcoidosis: From Antigen to Treatable Trait?

Microorganisms, 2022
Cutibacterium acnes (C. acnes, formerly Propionibacterium acnes) is considered to be a non-pathogenic resident of the human skin, as well as mucosal surfaces. However, it also has been demonstrated that C.
Raisa Kraaijvanger, Marcel Veltkamp
doaj   +1 more source

Drug Induced Interstitial Lung Disease [PDF]

The Open Respiratory Medicine Journal, 2012
With an increasing number of therapeutic drugs, the list of drugs that is responsible for severe pulmonary disease also grows. Many drugs have been associated with pulmonary complications of various types, including interstitial inflammation and fibrosis, bronchospasm, pulmonary edema, and pleural effusions. Drug-induced interstitial lung disease (DILD)
Schwaiblmair, Martin, Behr, Werner, Haeckel, Thomas, Märkl, Bruno, Foerg, Wolfgang, Berghaus, Thomas   +5 more
openaire   +3 more sources

Efficacy and Tolerability of Methotrexate and Methylprednisolone in a Comparative Assessment of the Primary and Long-Term Outcomes in Patients with Pulmonary Sarcoidosis

Diagnostics, 2021
Background: There is insufficient information in the literature on the comparative efficacy and tolerability of methotrexate (MTX) and methylprednisolone (MP) in patients with pulmonary sarcoidosis in assessing primary outcomes and the relapse rate ...
Volodymyr Gavrysyuk, Ievgenia Merenkova, Yaroslav Dziublyk, Nataliia Morska, Nataliia Pendalchuk, Olesia Bychenko, Nataliia Vlasova   +6 more
doaj   +1 more source

Rituximab‐induced interstitial lung disease [PDF]

American Journal of Hematology, 2005
AbstractThe aim of this study is to characterize rituximab‐induced interstitial lung disease (R‐ILD). The information on all reported cases of R‐ILD was reviewed. This analysis focused on patient characteristics, underlying disease, rituximab dosing schedule, and R‐ILD characteristic‐like symptoms, diagnosis, treatment, and outcomes. Sixteen cases of R‐
Stephanie A, Wagner, Apurva C, Mehta, Damian A, Laber   +2 more
openaire   +2 more sources

Comorbidities in unclassifiable interstitial lung disease

Respiratory Research, 2022
Background Comorbidities are common in interstitial lung diseases (ILD) and have an important association with survival, but the frequency and prognostic impact of comorbidities in unclassifiable interstitial lung disease (uILD) remains elusive. We aimed
Thomas Skovhus Prior, Charlotte Hyldgaard, Sebastiano Emanuele Torrisi, Sissel Kronborg-White, Claudia Ganter, Elisabeth Bendstrup, Michael Kreuter   +6 more
doaj   +1 more source

Assembly 12: interstitial lung diseases [PDF]

Breathe, 2018
Meet @ERStalk Assembly 12: interstitial lung diseases http://ow.ly/Bp0730m9zX4.
Antoniou, Katerina, Trachalaki, Athina, Bibaki, Eleni, Poletti, Venerino   +3 more
openaire   +3 more sources

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis

European Respiratory Review, 2019
Two antifibrotic medications (nintedanib and pirfenidone) were recommended (conditionally) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) in the 2015 IPF evidence-based guidelines.
Bridget F. Collins, Ganesh Raghu
doaj   +1 more source